Mutations or deletions in this gene have been shown to result in the development of juvenile polyposis syndrome, whereas weak expression of SMAD4 is known to associate with poor survival in patients with bowel cancer (Yan et al., 2016). This evidence concerns the gene SMAD4 and intestinal cancer.